Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
6.47
-0.01 (-0.15%)
At close: Mar 31, 2025, 4:00 PM
6.45
-0.02 (-0.24%)
After-hours: Mar 31, 2025, 5:37 PM EDT
Bausch Health Companies Market Cap
Bausch Health Companies has a market cap or net worth of $2.38 billion as of March 31, 2025. Its market cap has decreased by -29.80% in one year.
Market Cap
2.38B
Enterprise Value
23.04B
1-Year Change
-29.80%
Ranking
Category
Stock Price
$6.47
Market Cap Chart
Since December 1, 1998, Bausch Health Companies's market cap has increased from $953.20M to $2.38B, an increase of 149.74%. That is a compound annual growth rate of 3.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 2.38B | -19.57% |
| Dec 31, 2024 | 2.96B | 1.22% |
| Dec 29, 2023 | 2.93B | 28.88% |
| Dec 30, 2022 | 2.27B | -77.09% |
| Dec 31, 2021 | 9.92B | 34.30% |
| Dec 31, 2020 | 7.39B | -29.94% |
| Dec 31, 2019 | 10.54B | 63.22% |
| Dec 31, 2018 | 6.46B | -10.81% |
| Dec 29, 2017 | 7.24B | 43.49% |
| Dec 30, 2016 | 5.05B | -85.53% |
| Dec 31, 2015 | 34.88B | -27.40% |
| Dec 31, 2014 | 48.04B | 22.55% |
| Dec 31, 2013 | 39.20B | 115.15% |
| Dec 31, 2012 | 18.22B | 26.73% |
| Dec 30, 2011 | 14.38B | 69.40% |
| Dec 31, 2010 | 8.49B | 284.24% |
| Dec 31, 2009 | 2.21B | 45.15% |
| Dec 31, 2008 | 1.52B | -29.54% |
| Dec 31, 2007 | 2.16B | -36.05% |
| Dec 29, 2006 | 3.38B | -10.72% |
| Dec 30, 2005 | 3.78B | 44.09% |
| Dec 31, 2004 | 2.62B | -22.75% |
| Dec 31, 2003 | 3.40B | -18.31% |
| Dec 31, 2002 | 4.16B | -43.75% |
| Dec 31, 2001 | 7.39B | 53.06% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |